VE
Vera Therapeutics, Inc.
VERA · NASDAQ
$35.05 +3.36% (+$1.14)
1M +10.81%
Market Cap $2.41B
P/E Ratio -
Div. Yield -
ROE 84.13%
Bulios Fair Price
$25.07
28.5% downside
Trenutna cena
$35.05
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VERA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
26 /100
Expensive P/B 5.92x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 98.83%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 85.78%
Asset turnover 0.00x
ROE 84.13%
Debt
69 /100
Low Debt/Equity 0.18x
Int. coverage -34.70x
Current ratio 10.92x
Stability
50 /100
Moderate Beta 0.95x
Profitable years 0
EPS volatility 51.20%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VERA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marshall Fordyce
Employees
361
Headquarters
Brisbane
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report